Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03858556

Effect of Chuna Manipulation Therapy on Gait in Patients With Lumbar Disc Herniation

Prospective Observation Study of the Effect of Chuna Manipulation Therapy on Gait in Patients With Lumbar Disc Herniation

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Jaseng Medical Foundation · Academic / Other
Sex
All
Age
19 Years – 60 Years
Healthy volunteers
Accepted

Summary

Prospective Observation Study of the Effect of Chuna Manipulation Therapy on Gait in Patients With Lumbar Disc Herniation

Detailed description

To investigate the effect of Chuna manual therapy on gate, 20 patients with lumbar disc herniation were studied. The gait analysis was performed before the first treatment, after the seventh treatment, after the 14th treatment, and compared with the data of 20 normal subjects.

Conditions

Interventions

TypeNameDescription
PROCEDUREChuna manipulationChuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered to pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion.
DRUGHerbal medicineHerbal medicine will be administered in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).
PROCEDUREBee venom pharmacopunctureBee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
PROCEDUREPharmacopuncturePharmacopuncture consisting of select herbal ingredients will be administered at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
PROCEDUREAcupunctureAcupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDUREElectroacupunctureElectroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDURECuppingCupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.
OTHEROther intervention(s)Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.

Timeline

Start date
2019-02-27
Primary completion
2019-02-27
Completion
2019-02-27
First posted
2019-02-28
Last updated
2019-03-29

Source: ClinicalTrials.gov record NCT03858556. Inclusion in this directory is not an endorsement.